Erlonat - Erlotinib
Erlonat - Erlotinib belongs to a class of
medications called kinase inhibitors.
Erlotinib drug belongs to Epidermal Growth Factor Receptor (EGFR) tyrosine
kinase inhibitors class of medicines. It is required in cancer chemotherapy
medication and is mostly preferred for the treatment of non-small cell lung
cancer. Consumption of this medicine interferes with the growth of cancer
cells and helps in slowing down their growth in the human body. This drug is
indicated for treatment of the patients suffering from advanced or
metastatic non-small cell lung cancer.
Erlonat is used for the treatment of non-small cell lung cancer
25 mg, 100 mg & 150 mg tablets.
Natco Pharma Ltd. (INDIA)
Erlonat is a prescription drug and should be used under proper medical
guidance and advice.